NMC
PIII icon

Nine Masts Capital’s P3 Health Partners PIII Stock Holding History

Nine Masts Capital’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,964
Closed -$55.3K – 266
2026
Q1 		$55.3K Buy
+17,964
New +$47.3K 0.01% 134

Other funds holding PIII

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nine Masts Capital's PIII Position: Q2 2026 in Review

Nine Masts Capital sold out of P3 Health Partners (PIII) in Q2 2026, closing a stake of 17,964 shares — an estimated $55.3K sold.

Nine Masts Capital first reported a position in PIII in Q1 2026 and held it in 1 quarter. The position peaked at $55.3K in Q1 2026. 21 funds tracked by Wall St. Rank hold PIII as of Q2 2026.

  • Nine Masts Capital reported no remaining P3 Health Partners position as of Q2 2026 after selling out during the quarter.
  • Nine Masts Capital sold 17,964 P3 Health Partners shares in Q2 2026, an estimated $55.3K.
  • Nine Masts Capital first reported a position in P3 Health Partners in Q1 2026 and held it in 1 quarter.
  • Nine Masts Capital's P3 Health Partners position peaked at $55.3K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.